Stockreport

The Ratings Game: Biogen’s key Alzheimer’s disease drug is facing potential signs of trouble [MarketWatch]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF Biogen’s key Alzheimer’s disease drug is facing potential signs of trouble Biogen Inc.’s crucial Alzheimer’s disease drug aducanumab is still a year or two from releasin [Read more]